Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Net Income (2016 - 2025)

Historic Net Income for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $16.8 million.

  • Macrogenics' Net Income fell 7012.56% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.6 million, marking a year-over-year increase of 2512.45%. This contributed to the annual value of -$67.0 million for FY2024, which is 63930.23% down from last year.
  • Latest data reveals that Macrogenics reported Net Income of $16.8 million as of Q3 2025, which was down 7012.56% from -$36.3 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Net Income registered a high of $56.3 million during Q3 2024, and its lowest value of -$66.6 million during Q1 2022.
  • For the 5-year period, Macrogenics' Net Income averaged around -$32.9 million, with its median value being -$41.8 million (2022).
  • In the last 5 years, Macrogenics' Net Income tumbled by 258368.66% in 2021 and then skyrocketed by 25860.8% in 2024.
  • Macrogenics' Net Income (Quarter) stood at -$58.2 million in 2021, then soared by 120.58% to $12.0 million in 2022, then plummeted by 511.87% to -$49.4 million in 2023, then soared by 68.75% to -$15.4 million in 2024, then surged by 209.09% to $16.8 million in 2025.
  • Its Net Income stands at $16.8 million for Q3 2025, versus -$36.3 million for Q2 2025 and -$42.7 million for Q1 2025.